ARTL
Price
$1.12
Change
-$0.00 (-0.00%)
Updated
Oct 4 closing price
30 days until earnings call
LSTA
Price
$3.00
Change
+$0.06 (+2.04%)
Updated
Oct 4 closing price
32 days until earnings call
Ad is loading...

ARTL vs LSTA

Header iconARTL vs LSTA Comparison
Open Charts ARTL vs LSTABanner chart's image
Artelo Biosciences
Price$1.12
Change-$0.00 (-0.00%)
Volume$1.7K
CapitalizationN/A
Lisata Therapeutics
Price$3.00
Change+$0.06 (+2.04%)
Volume$2.23K
CapitalizationN/A
View a ticker or compare two or three
ARTL vs LSTA Comparison Chart
Loading...
ARTL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
LSTA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ARTL vs. LSTA commentary
Oct 06, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARTL is a StrongBuy and LSTA is a Hold.

COMPARISON
Comparison
Oct 06, 2024
Stock price -- (ARTL: $1.12 vs. LSTA: $3.00)
Brand notoriety: ARTL and LSTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARTL: 25% vs. LSTA: 20%
Market capitalization -- ARTL: $3.62M vs. LSTA: $24.71M
ARTL [@Biotechnology] is valued at $3.62M. LSTA’s [@Biotechnology] market capitalization is $24.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARTL’s FA Score shows that 1 FA rating(s) are green whileLSTA’s FA Score has 1 green FA rating(s).

  • ARTL’s FA Score: 1 green, 4 red.
  • LSTA’s FA Score: 1 green, 4 red.
According to our system of comparison, LSTA is a better buy in the long-term than ARTL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARTL’s TA Score shows that 5 TA indicator(s) are bullish while LSTA’s TA Score has 3 bullish TA indicator(s).

  • ARTL’s TA Score: 5 bullish, 2 bearish.
  • LSTA’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ARTL is a better buy in the short-term than LSTA.

Price Growth

ARTL (@Biotechnology) experienced а +2.31% price change this week, while LSTA (@Biotechnology) price change was +3.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.46%. For the same industry, the average monthly price growth was +1.89%, and the average quarterly price growth was -5.77%.

Reported Earning Dates

ARTL is expected to report earnings on Mar 26, 2025.

LSTA is expected to report earnings on Mar 27, 2025.

Industries' Descriptions

@Biotechnology (+1.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LSTA($24.7M) has a higher market cap than ARTL($3.62M). LSTA YTD gains are higher at: 9.941 vs. ARTL (-20.343). ARTL has higher annual earnings (EBITDA): -10.31M vs. LSTA (-23.93M). LSTA has more cash in the bank: 38.3M vs. ARTL (5.6M). ARTL has less debt than LSTA: ARTL (120K) vs LSTA (176K). ARTL (0) and LSTA (0) have equivalent revenues.
ARTLLSTAARTL / LSTA
Capitalization3.62M24.7M15%
EBITDA-10.31M-23.93M43%
Gain YTD-20.3439.941-205%
P/E RatioN/AN/A-
Revenue00-
Total Cash5.6M38.3M15%
Total Debt120K176K68%
FUNDAMENTALS RATINGS
ARTL vs LSTA: Fundamental Ratings
ARTL
LSTA
OUTLOOK RATING
1..100
1076
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
15
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9896
PRICE GROWTH RATING
1..100
8256
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARTL's Valuation (13) in the null industry is in the same range as LSTA (15). This means that ARTL’s stock grew similarly to LSTA’s over the last 12 months.

ARTL's Profit vs Risk Rating (100) in the null industry is in the same range as LSTA (100). This means that ARTL’s stock grew similarly to LSTA’s over the last 12 months.

LSTA's SMR Rating (96) in the null industry is in the same range as ARTL (98). This means that LSTA’s stock grew similarly to ARTL’s over the last 12 months.

LSTA's Price Growth Rating (56) in the null industry is in the same range as ARTL (82). This means that LSTA’s stock grew similarly to ARTL’s over the last 12 months.

LSTA's P/E Growth Rating (100) in the null industry is in the same range as ARTL (100). This means that LSTA’s stock grew similarly to ARTL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARTLLSTA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 11 days ago
88%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
81%
View a ticker or compare two or three
Ad is loading...
ARTL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
LSTA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMPX1.220.16
+15.09%
Amprius Technologies
VRM10.130.37
+3.79%
Vroom
CC19.570.34
+1.77%
Chemours Company (The)
ATEN14.310.16
+1.13%
A10 Networks
STM28.430.19
+0.67%
STMicroelectronics NV

ARTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARTL has been loosely correlated with PALI. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ARTL jumps, then PALI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARTL
1D Price
Change %
ARTL100%
-0.36%
PALI - ARTL
34%
Loosely correlated
-3.65%
CRMD - ARTL
32%
Poorly correlated
+7.36%
FATE - ARTL
31%
Poorly correlated
+3.21%
LSTA - ARTL
29%
Poorly correlated
+2.09%
VTYX - ARTL
28%
Poorly correlated
+1.94%
More

LSTA and

Correlation & Price change

A.I.dvisor tells us that LSTA and ARWR have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LSTA and ARWR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LSTA
1D Price
Change %
LSTA100%
+2.09%
ARWR - LSTA
31%
Poorly correlated
-0.16%
PRME - LSTA
30%
Poorly correlated
+2.93%
NTLA - LSTA
30%
Poorly correlated
+1.93%
ABCL - LSTA
27%
Poorly correlated
+0.81%
KROS - LSTA
27%
Poorly correlated
+1.67%
More